MAXIS GBN whitepaper highlights massive uptick in cancer incidence
MAXIS Global Benefits Network (MAXIS GBN) has published a new whitepaper with data that shows cancer incidence was 155% higher in 2024 when compared to the average of 2017-2019, with the associated costs rising by a staggering 234% in the same period.
MAXIS GBN added that perhaps most shocking of all is the average age of claimants, which has dropped to 40 years of age in 2024, down from 47 across the 2017-2019 period.
The whitepaper discusses the impact of the COVID-19 pandemic on the scale of the cancer threat globally – it notes that delays in screenings and treatments during the pandemic have led to a surge in late-stage cancer cases, placing a huge strain on healthcare systems around the world.
MAXIS GBN’s 2025 whitepaper looks in-depth at the growing impact of rising cancer rates on multinational employers and insurers.
The whitepaper uses MAXIS GBN’s global claims data, drawn from standardised, anonymised data from millions of claimants around the world, to provide practical strategies for addressing claims trends.
Cancer is a topic that has dominated discussions in the global health space in recent years. The surge in cases has placed unprecedented strain on healthcare systems all over the world and presents a profound challenge for multinational employers and insurers.
The whitepaper also looks at a wide range of topics related to cancer, including the most-common pre-existing conditions that show before a cancer diagnosis, the industries that most often correlate with certain cancer types and the impact of missed cancer screenings.
MAXIS GBN says that the whitepaper doesn’t aim to simply present findings and highlight problems. Instead, it offers “practical solutions for both multinational employers and insurers, aiming to help them optimise, innovate and lead in the cancer space.”
MAXIS GBN hopes these insights can help multinationals truly care for their people and address this crisis head on. Multinational employers who write their EB risks via a captive are particularly well-positioned to do so, with greater control over plan design meaning they can respond directly to the strategies proposed in the whitepaper and begin implementing.
Dr Leena Johns, chief health & wellness officer, MAXIS GBN, authored the whitepaper. She said: “Cancer is something that impacts us all, whether directly or through our loved ones, and for this reason it can be a difficult topic to discuss. But it’s also the scale of its impact that means it vital that we do talk about it.
“I knew that cancer had to be the focus of our 2025 whitepaper because the disturbing story being told by our data revealed the urgency of this crisis. I wanted to provide a clear snapshot of the cancer crisis and share real, actionable strategies and solutions for multinationals and insurers.
“This is a huge topic and the insights can be daunting, but there is hope. I truly believe that employers and insurers should feel empowered to take action: they are at the forefront of this crisis and are in a unique position to drive meaningful change, ultimately leading to happier, healthier and more productive workforces.”
The full whitepaper can be downloaded at maxis-gbn.com/cancer.
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
